60 Degrees Pharmaceuticals to Sponsor Pilot Study of
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....
United States Patrick Gaynes Sheilaa Burke United States Army Exchange Commission Materiel Development Activity
Source: globenewswire.com